This is an innovative program using both ultrasound and blood tests to provide information to parents very early in pregnancy about their risk to have a fetus affected by genetic conditions such as Down syndrome and Trisomy 18. First Trimester Aneuploidy Screening offers the opportunity to obtain information about genetic risks before the end of the first trimester.